Bookmark

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study

Autoimmune Diseases , Volume 2012 (2012) Hindawi Publishing CorporationApr 5, 2012

Free

Download PDF
11 pages

Loading next page...

Switch to Continuous Viewing mode

 
/lp/hindawi-publishing-corporation/recombinant-t-cell-receptor-ligand-rtl-for-treatment-of-multiple-0ZhGdiy3F0
Title
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study
Journal
Autoimmune Diseases , Volume 2012 (2012) Hindawi Publishing Corporation – Apr 5, 2012
Publisher
Hindawi Publishing Corporation
Copyright
Copyright © 2012 Vijayshree Yadav et al.
ISSN
2090-0422
eISSN
2090-0430
Publisher site
Get PDF